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A number of cell surface markers are expressed on resting peripheral blood (PB) T 
cells (1).  However, there are a  number of surface markers that are expressed only in 
low proportions  or  not  at  all  on  resting  T  cells,  but  that  are  clearly expressed  in 
varying proportions on activated T  cells. Among these markers of activated T  cells, 
the  receptors  for the  Fc portion  of IgG (FcyR)  are on  small  fractions of PB  sheep 
erythrocyte (E)-rosetting cells, usually referred to as Ty cells (2,  3). The proportions 
of FcTR-positive cells increase markedly upon activation of the cell (4).  In addition, 
Ia-like antigens are expressed on a  small proportion of freshly isolated circulating T 
cells; these are included within the Ty fraction (5). Again, upon activation of T  cells, 
variable  proportions  will  express  Ia-like  antigens  (6-8).  Recently,  a  monoclonal 
antibody  (4F2)  has  been  described  which  binds  to  a  non-Ia,  120,000-mol  wt  cell 
surface antigen  present on resting PB monocytes, but which  is present  in negligible 
amounts on resting PB lymphocytes (9,  10). However, the 4Fz antigen is expressed on 
a  large  proportion  of lymphocytes which  have been  activated  by mitogen  and/or 
alloantigen stimulation (9). 
The precise identity of the  mixed lymphocyte reaction  (MLR)-activated  specific 
cytotoxic T  cell (CTL)  in humans has not been characterized by currently available 
cell surface markers. 
In this study we have analyzed MLR-activated T cells to determine the relationship 
between  specific  cytotoxicity  and  the  phenotypic  expression  of  these  activation 
markers. The results indicate that CTL are found exclusively in a population of cells 
lacking detectable FcyR (FcyR-) but expressing 4F2 antigen.  By contrast, CTL were 
detectable in both the Ia-positive and Ia-negative population of activated T  cells. 
Materials and Methods 
Cell Separations.  Mononuclear cells were obtained from heparinized PB by standard Ficoll- 
Hypaque separation and adherent cells were removed from the mononuclear cell suspensions 
by adherence to plastic Petri dishes. E-rosetting lymphocytes were separated from nonrosetting 
cells by fractionation of rosetting cells over two sequential Ficoll-Hypaque centrifugations (11). 
T  cells bearing receptors for IgM (T#) were isolated  as previously described (12). Stimulator 
cells for the MLR were prepared by two sequential Ficoll-Hypaque fractionations of E-rosetting 
cells from mononuclear cells to obtain E-rosette-depleted cell suspensions. These cells were then 
irradiated with 5,000 rad. 
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Cell Cultures.  MLR were set up by culturing purified T cells or T# cells either in macrowe|ls 
(2  X  10  a cells) or in round-bottomed mierowelis (105 cells) with equal numbers of irradiated 
allogeneic E-rosette-depleted ceils in RPMI-1640 that contained 10% fetal calf serum. Controls 
included both responder and stimulator cells cultured alone. To evaluate the cell proliferation, 
tritiated thymidine ([SH]TdR) was added (1 /~Ci/well) to triplicate microwell cultures  18  h 
before harvesting,  and  the  [SH]TdR  uptake  was  determined  in  a  scintillation counter.  In 
parallel experiments cells were harvested after 7 d, passed through a Ficoll-Hypaque gradient 
to remove dead cells, and after washing twice, cells were counted and the percentages of E- 
rosetting  cells  determined.  When  the  proportion  of  E-rosettes  was  >95%,  no  additional 
purification was performed. When  the proportion was <95%,  E-rosetting cells were further 
isolated by additional Ficoll-Hypaque density gradient centrifugations. 
Enumeration and Isolation of MLR-activated  Cells Expressing Surface FcyR, la, or 4F2 Antigen.  Cells 
with surface FcyR were isolated as previously described by a  rosetting technique using ox 
erythrocytes sensitized with purified rabbit IgG antibodies (12).  Rosetting cells (FcTR  +) were 
isolated  from  nonrosetting  cells  (FcTR-)  by  pelleting them  at  least  twice  through  Ficoll- 
Hypaque gradients. Ox erythrocytes were  lysed with  NH4Ci  buffer.  The  FcTR- cells were 
sham-treated with NH4CI. Monoclonal antibodies 4F2 and D1/12 were prepared and used as 
previously described (10,  13). For evaluation of the percentage of Ia  + and 4F2  + cells and for 
their isolation, T cell suspensions were reacted with saturating amounts of monoclonal antibody. 
The D1/12  monoclonal anti-Ia antibody was kindly provided by Dr. R. Accolla and Dr. S. 
Carrel of the Ludwig Institute for Cancer Research, Epilanges sur Lausanne, Switzerland. A 
fluoresceinated  goat  anti-mouse  antiserum  was  used  as  the  second  reagent  in  saturating 
concentrations  for  analysis on  the  fluorescence-activated cell  sorter  (FACS  II;  BD  FACS 
Systems, Mountain View, Calif.). Background fluorescence was obtained by FACS analysis of 
the same cell suspensions incubated with a mouse gamma-2 globulin in place of D1/12  (Ia) or 
4F2 monoelonal antibodies. 4F2 or D1/12-1abeled cells were also enumerated and were exclu- 
sively isolated by means of a  rosetting technique using ox erythrocytes coated with staphylo- 
coccal A  protein (13).  Both rosetting and nonrosetting cells were treated with NH4CI  lysing 
buffer after isolation. 
After activation in the MLR, the proportions of cells positive for Ia or 4F2 antigen were 
similar in both FACS and rosetting analysis. The percentage of Ia  + cells ranged from 30 to 50% 
of responder T cells; both small and large cells were Ia  +. 4F2 antigen-bearing lymphocytes were 
40-60% of the responder T  cells and were all large cells. FcyR  + cells ranged from 20 to 50% of 
the responder T  cells of a  7-d MLR--both large and small cells expressed FcyR. 
Cytotoxicity Assay.  E-rosetting T  cells from a  7-d MLR or T  cells fractionated according to 
surface FcyR, Ia, or 4F2 antigen were tested for their cytotoxic capacity against the relevant 
target cells, which had been stimulated for 3 d with phytohemagglutinin. 5 ×  10  a target cells 
labeled with 51Cr were incubated with varying numbers of effector cells (from  1:1  to  100:1 
ratios). The plates were centrifuged and then incubated for 4 h at 37°C. Cytolysis was assessed 
by counting the radioactivity of 0.1 ml supernate for 1 rain in a scintillation counter (Packard 
Instrument Co., Inc., Downers Grove, Ill.). The specific lysis was calculated according to the 
method ofCerottini et al. (14). 
Results and  Discussion 
Purified T  lymphocytes were used as responder cells against allogeneic irradiated 
E-rosette-depleted cells. After a  7-d MLR, E-rosetting cells were isolated and further 
fractionated according to the presence of FcTR, surface Ia, or 4F2 antigen.  Unfrac- 
tionated responder T  lymphocytes (total T  cells) and the various cell fractions bearing 
or lacking the above-mentioned markers were analyzed for their cytotoxic capability 
against the relevant target cells. Fig.  1 shows a  typical experiment. The presence of 
Ia-like antigens recognized by D1/12 monoelonal antibody did not discriminate cells 
manifesting specific cytotoxicity, because unfractionated responder cells, Ia  +, and Ia- 
fractions killed the  target  with  similar efficiency  (Fig.  1).  These  experiments  were 
performed four separate times with similar results. On the other hand, fractionation MORETTA  ET  AL. 
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FI~;.  1.  Cytotoxic capacity of 7-d MLR T  cells fractionated according to surface Ia antigens. The 
cytotoxicity induced by Ia  + or Ia- effector T  cells was similar to that of unfractionated T  cells. Cells 
were fractionated by rosetting D1/12-coated responder cells with staphylococcal protein A-coated 
human  erythrocytes.  Similar  results were  obtained  in  four  other  experiments  using either  the 
rosetting technique or the fractionation by FACS II. 
of responder T  cells according to surface FcyR demonstrated that cytotoxic cells were 
present  exclusively among  the  FcyR-  fraction  (Fig.  2).  These  experiments  were 
performed 10 separate times with similar results. By contrast, cytotoxic T  cells were 
restricted to the population bearing 4F2 antigen (Fig. 3) as determined by five separate 
experiments.  It  is  noteworthy that  similar results were obtained in  experiments in 
which purified T# cells were used as responders (data not shown). Thus, responder T 
cells  that  express  none of these  activation  markers  at  the  initiation  of the  MLR 
(purified T# cells) are equally capable of ultimately expressing them. 
These results have clearly demonstrated  that  the MLR-generated CTL are con- 
tained  in  the  4F2  +  and  FcyR-  cell  fractions.  Therefore, it  is  possible,  after MLR 
activation, to selectively enrich or deplete specific CTL on the basis of the presence or 
absence of different activation markers. 
Because  CTL  are  restricted  to  the  cells  bearing  the  4F2  antigen,  but  lacking 
detectable FcyR, an obvious question is whether all the 4F2  + cells are FcyR- and, 
conversely, whether all of the FcyR- cells express 4F2 antigen. Preliminary experiments 
have shown that this is not the case and that 4F2  + cells include variable proportions 
of FcyR  + cells (up to 30%), whereas FcyR- cells can comprise up to 50% of 4F2- cells. 
Thus, the combined use of FcyR and 4F2 antibody allows one to further restrict the 
cytotoxic cells to the 4F2  +, FcyR- fraction, which usually accounts for 30-40% of the 
responder T  cells. 
As the fraction of cells that expresses 4F2 antigen includes all the specific CTL, the 
question  arises  whether  this  surface structure is  directly involved in  the cytotoxic 
capacity of the cells. In this regard, addition of high concentration of 4F2 monoclonal 
antibody to the cytolytic assay had no effect on the target cell killing. In addition, it 
is possible that the positive selection of FcyR  + cells generated in MLR by rosetting 
techniques could affect the cytotoxic capacity of the cells themselves, because it  is 
known that  interaction of PB Ty cells with IgG immune complexes induces loss of 216  MORETTA  ET AL.  BRIEF  DEFINITIVE REPORT 
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Fro.  2.  Cytotoxic activity of 7-d MLR  responder T  cells fractionated according to surface FcyR, 
Cells cytotoxic against the specific target were present exclusively in the FcTR- fraction of activated 
T  cells. 
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Fie.  3.  Cytotoxic  activity  of  7-d  MLR  T  cells  fractionated  according  to  the expression of 4Fa 
antigen. Cells cytotoxic against the specific target were present exclusively in  the 4F~ +  fraction. 
detectable cell surface FcTR (15), and that modulation of FcTR interferes with certain 
functional  activities  of the  cells,  such  as  responses  to  allogeneic  cells  or  to  T  cell 
mitogens  (16,  17).  However, Fc7R + cells  generated  in MLR  do not lose their FcTR 
upon  interaction  with  IgG  immune  complexes,  and  most  importantly,  they  are 
extremely effective in antibody-dependent  cellular cytotoxicity and natural killer celt 
assays (Mingari et al. Manuscript in preparation.). In addtion, the FcTR- cell fraction 
was always more active than the unfractionated population,  further suggesting  that 
specific CTL are indeed poorly represented in the FcyR + fraction. 
The precise nature and function of the FcyR + cells that were generated in the MLR 
are still uncertain. There is little doubt about the T  cell nature of these cells because 
they express  various T  cell  markers (Mingari  et  al.  Manuscript  in preparation.).  In 
addition, these MLR-generated Ty cells are detectable in high proportions even when 
the responder cells are T 7  depleted before the inception of the MLR as was done in 
the experiments employing purified T/~ cells as responder cells. This would rule out 
the possibility of an expansion of cytotoxic cells originally present in the T T fraction 
as a consequence of the release of nonspecific growth factors during the course of the 
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Summary 
Mixed lymphocyte reaction  (MLR)-activated T  cells were analyzed according to 
the expression of various cell surface markers by the specific cytotoxic T  lymphocytes 
(CTL) generated in the MLR. CTL were found exclusively in a  population of MLR- 
activated T  cells that  lacked detectable FcyR but  that  expressed a  surface antigen 
recognized by the 4F~ monoclonal antibody. In contrast, CTL were found in both the 
Ia-positive  and  Ia-negative  cells  after  MLR  activation.  Thus,  the  specific  CTL 
generated  in  the  allogeneic  MLR  can  be  identified  and  isolated  by  virtue  of the 
expression of a  particular cell surface marker. 
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